M Kerr1, E Barron2, P Chadwick3, T Evans2, W M Kong4, G Rayman5, M Sutton-Smith4, G Todd4, B Young6, W J Jeffcoate7. 1. Insight Health Economics Ltd, London, UK. 2. Public Health England, London, UK. 3. College of Podiatry, London, UK. 4. London North West University Healthcare NHS Trust, London, UK. 5. Ipswich Hospital NHS Trust, Ipswich, UK. 6. National Diabetes Audit, London, UK. 7. Nottingham University Hospitals NHS Trust, Nottingham, UK.
Abstract
AIM: To estimate the healthcare costs of diabetic foot disease in England. METHODS: Patient-level data sets at a national and local level, and evidence from clinical studies, were used to estimate the annual cost of health care for foot ulceration and amputation in people with diabetes in England in 2014-2015. RESULTS: The cost of health care for ulceration and amputation in diabetes in 2014-2015 is estimated at between £837 million and £962 million; 0.8% to 0.9% of the National Health Service (NHS) budget for England. More than 90% of expenditure was related to ulceration, and 60% was for care in community, outpatient and primary settings. For inpatients, multiple regression analysis suggested that ulceration was associated with a length of stay 8.04 days longer (95% confidence interval 7.65 to 8.42) than that for diabetes admissions without ulceration. CONCLUSIONS: Diabetic foot care accounts for a substantial proportion of healthcare expenditure in England, more than the combined cost of breast, prostate and lung cancers. Much of this expenditure arises through prolonged and severe ulceration. If the NHS were to reduce the prevalence of diabetic foot ulcers in England by one-third, the gross annual saving would be more than £250 million. Diabetic foot ulceration is a large and growing problem globally, and it is likely that there is potential to improve outcomes and reduce expenditure in many countries.
RCT Entities:
AIM: To estimate the healthcare costs of diabetic foot disease in England. METHODS:Patient-level data sets at a national and local level, and evidence from clinical studies, were used to estimate the annual cost of health care for foot ulceration and amputation in people with diabetes in England in 2014-2015. RESULTS: The cost of health care for ulceration and amputation in diabetes in 2014-2015 is estimated at between £837 million and £962 million; 0.8% to 0.9% of the National Health Service (NHS) budget for England. More than 90% of expenditure was related to ulceration, and 60% was for care in community, outpatient and primary settings. For inpatients, multiple regression analysis suggested that ulceration was associated with a length of stay 8.04 days longer (95% confidence interval 7.65 to 8.42) than that for diabetes admissions without ulceration. CONCLUSIONS:Diabetic foot care accounts for a substantial proportion of healthcare expenditure in England, more than the combined cost of breast, prostate and lung cancers. Much of this expenditure arises through prolonged and severe ulceration. If the NHS were to reduce the prevalence of diabetic foot ulcers in England by one-third, the gross annual saving would be more than £250 million. Diabetic foot ulceration is a large and growing problem globally, and it is likely that there is potential to improve outcomes and reduce expenditure in many countries.
Authors: Michelle R Kaminski; Jonathan Golledge; Joel W J Lasschuit; Karl-Heinz Schott; James Charles; Jane Cheney; Anita Raspovic Journal: J Foot Ankle Res Date: 2022-07-06 Impact factor: 3.050
Authors: Guilherme Pena; Beatrice Kuang; Zygmunt Szpak; Prue Cowled; Joseph Dawson; Robert Fitridge Journal: Adv Wound Care (New Rochelle) Date: 2019-10-23 Impact factor: 4.730
Authors: Francesca M Chappell; Fay Crawford; Margaret Horne; Graham P Leese; Angela Martin; David Weller; Andrew J M Boulton; Caroline Abbott; Matilde Monteiro-Soares; Aristidis Veves; Richard D Riley Journal: BMJ Open Diabetes Res Care Date: 2021-05